EXEL..$4.80http://www.biopharmcatalyst.com/asco2012/. View all the abstracts here. Again...a solid service provided for everyone here & good for biotech traders. Look at the Phase 2 & 3 data being presented. 8 abstracts in all. EXEL will be one of the busier companies at ASCO this year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.